Literature DB >> 9141213

Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick.

M Canales1, A Enríquez, E Ramos, D Cabrera, H Dandie, A Soto, V Falcón, M Rodríguez, J de la Fuente.   

Abstract

A gene coding for the Bm86 tick protein was recently cloned, expressed in Pichia pastoris and shown to induce an inmunological response in cattle against ticks. Moreover, the Gavac vaccine (Heber Biotec S.A., Havana, Cuba), which contains this recombinant protein, has proved to control the Boophilus microplus populations under field conditions. This paper reviews the development and large-scale production of this vaccine, the efficacy of the resulting product and the strategy followed in designing its production plant. The production plant fulfills biosafety requirements and GMP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141213     DOI: 10.1016/s0264-410x(96)00192-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  39 in total

1.  Cross-bred cattle protected against Hyalomma anatolicum anatolicum by larval antigens purified by immunoaffinity chromatography.

Authors:  S Ghosh; M H Khan; N Ahmed
Journal:  Trop Anim Health Prod       Date:  1999-10       Impact factor: 1.559

2.  Cloning and secreted expression of the extracellular domain of the mumps virus fusion protein in Pichia pastoris.

Authors:  B McAleer; B Rima
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

3.  Polymorphism of the bm86 gene in South American strains of the cattle tick Boophilus microplus.

Authors:  Sidimar Sossai; Ana P Peconick; Policarpo A Sales-Junior; Francismar C Marcelino; Marlene I Vargas; Elisangela S Neves; Joaquín H Patarroyo
Journal:  Exp Appl Acarol       Date:  2005       Impact factor: 2.132

4.  Gene expression during the early stages of host perception and attachment in adult female Rhipicephalus microplus ticks.

Authors:  Kylie G Bendele; Felix D Guerrero; Connor Cameron; Deanna M Bodine; Robert J Miller
Journal:  Exp Appl Acarol       Date:  2019-09-24       Impact factor: 2.132

5.  Experimental immunisation of crossbred cattle with glycoproteins isolated from the larvae of Hyalomma anatolicum anatolicum and Boophilus microplus.

Authors:  N K Singh; S Ghosh
Journal:  Exp Appl Acarol       Date:  2003       Impact factor: 2.132

6.  Two initial vaccinations with the Bm86-based Gavacplus vaccine against Rhipicephalus (Boophilus) microplus induce similar reproductive suppression to three initial vaccinations under production conditions.

Authors:  Milagros Vargas; Carlos Montero; Dunia Sánchez; Danny Pérez; Mario Valdés; Aymé Alfonso; Marisdania Joglar; Héctor Machado; Elsa Rodríguez; Luis Méndez; Ricardo Lleonart; Marisela Suárez; Erlinda Fernández; Mario P Estrada; Alina Rodríguez-Mallón; Omar Farnós
Journal:  BMC Vet Res       Date:  2010-09-16       Impact factor: 2.741

7.  Experimental efficacy of a vaccine against Rhipicephalus australis.

Authors:  Thomas Hüe; Julie Petermann; Romain Bonnefond; Isabelle Mermoud; Dewi Rantoen; Tony Vuocolo
Journal:  Exp Appl Acarol       Date:  2017-11-06       Impact factor: 2.132

8.  Identification and characterization of Rhipicephalus (Boophilus) microplus candidate protective antigens for the control of cattle tick infestations.

Authors:  Consuelo Almazán; Rodolfo Lagunes; Margarita Villar; Mario Canales; Rodrigo Rosario-Cruz; Frans Jongejan; José de la Fuente
Journal:  Parasitol Res       Date:  2009-11-27       Impact factor: 2.289

9.  Vaccination with recombinant Boophilus annulatus Bm86 ortholog protein, Ba86, protects cattle against B. annulatus and B. microplus infestations.

Authors:  Mario Canales; Consuelo Almazán; Victoria Naranjo; Frans Jongejan; José de la Fuente
Journal:  BMC Biotechnol       Date:  2009-03-31       Impact factor: 2.563

10.  Purification and characterization of two larval glycoproteins from the cattle tick, Boophilus annulatus.

Authors:  Amr E El Hakim; Yasser E Shahein; Amira M Abouelella; Mohamed E Selim
Journal:  J Vet Sci       Date:  2007-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.